# Mifepristone for Labor Induction

> **NCT05097326** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 30 (actual)

## Conditions studied

- Induced Vaginal Delivery

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT05097326
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-27
- **Primary completion:** 2023-04-29
- **Final completion:** 2023-04-29
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05097326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05097326, "Mifepristone for Labor Induction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05097326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
